Profil
Marc Crouton has held positions at Fresenius Kabi Groupe France and Fresenius Kabi AG.
He is currently working at Fresenius Kabi Groupe France as Chairman and at Fresenius Kabi AG as a Member-Management Board.
Postes actifs de Marc Crouton
| Sociétés | Poste | Début |
|---|---|---|
Fresenius Kabi Groupe France
 Fresenius Kabi Groupe France Financial ConglomeratesFinance Part of Fresenius Medical Care AG, Fresenius Kabi Groupe France is an investment holding French company. The company is based in Sèvres, France. The company was founded in 1996. Alain Mollard has been the CEO of the company since 2021. | Président | 10/12/2011 |
Fresenius Kabi AG
 Fresenius Kabi AG Pharmaceuticals: MajorHealth Technology Fresenius Kabi AG manufactures medical devices for therapies. It specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. The firm offers infusion solutions for fluid substitution, blood volume replacement, intravenously administered drugs as well as the respective medical devices for the application, pump systems and infusion management systems. The company was founded in 1999 and is headquartered in Bad Homburg, Germany. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Fresenius Kabi Groupe France
Fresenius Kabi Groupe France Financial ConglomeratesFinance Part of Fresenius Medical Care AG, Fresenius Kabi Groupe France is an investment holding French company. The company is based in Sèvres, France. The company was founded in 1996. Alain Mollard has been the CEO of the company since 2021. | Finance |
Fresenius Kabi AG
Fresenius Kabi AG Pharmaceuticals: MajorHealth Technology Fresenius Kabi AG manufactures medical devices for therapies. It specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. The firm offers infusion solutions for fluid substitution, blood volume replacement, intravenously administered drugs as well as the respective medical devices for the application, pump systems and infusion management systems. The company was founded in 1999 and is headquartered in Bad Homburg, Germany. | Health Technology |
